Katharine Hsu
Katharine Chia-Rae Hsu | |
|---|---|
| Alma mater | Stanford University (BS, MS) Cornell University (PhD, MD) |
| Known for | Director of Tri-Institutional MD–PhD Program since 2021 |
| Scientific career | |
| Fields | Hematology, oncology |
| Institutions |
|
| Thesis | Mechanisms of TNF receptor action: Studies using chimeric receptor mutants (1993) |
| Doctoral advisor | Moses Chao |
Katharine Chia-Rae Hsu is an American physician-scientist with a field of research in human natural killer cells. A professor of medicine at Weill Cornell Medicine, she has served as the director of the Tri-Institutional MD–PhD Program since April 2021.